Quality of Life With TESTIM®

NCT ID: NCT01148433

Last Updated: 2011-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

157 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-05-31

Study Completion Date

2011-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present non-interventional study is to document the testosterone levels in patients with clinical symptoms such as loss of sexual desire indicating hypogonadism (testosterone deficiency syndrome). During testosterone replacement therapy with TESTIM®, the changes in the quality of life - especially with respect to motivation, activity and fatigue - of hypogonadal patients will be documented and correlated with the testosterone levels during the course of therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypogonadism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TESTIM® - drug given by prescription

Male patients with Hypogonadism

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* therapeutic need according to SPC
* written informed consent

Exclusion Criteria

* contraindications according to SPC
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ferring Arzneimittel GmbH

INDUSTRY

Sponsor Role collaborator

Ferring Pharmaceuticals

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Development Support

Role: STUDY_DIRECTOR

Ferring Pharmaceuticals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Investigational Site

Apolda, , Germany

Site Status

Investigational Site

Aschersleben, , Germany

Site Status

Investigational Site

Bad Bergzaben, , Germany

Site Status

Investigational Site

Bad Schönborn, , Germany

Site Status

Investigational Site

Bautzen, , Germany

Site Status

Investigational Site, Helene-Weigel-Platz 10

Berlin, , Germany

Site Status

Investigational Site, Kurfürstendamm 33

Berlin, , Germany

Site Status

Investigational Site, Königin-Elisabeth-Straße 1

Berlin, , Germany

Site Status

Investigational Site, Tempelhofer Damm 227

Berlin, , Germany

Site Status

Investigational Site, Turmstraße 82

Berlin, , Germany

Site Status

Investigational Site, Wilmersdorfer Straße 62

Berlin, , Germany

Site Status

Investigational site

Bielefeld, , Germany

Site Status

Investigational Site

Bramsche, , Germany

Site Status

Investigational Site, Humboldtstraße 4

Braunschweig, , Germany

Site Status

Investigational site, Ritterbrunen 7

Braunschweig, , Germany

Site Status

Investigational Site, Dr.-Franz-Mertens-Straße 8

Bremerhaven, , Germany

Site Status

Investigational Site

Bremerhaven, , Germany

Site Status

Investigational Site

Büdingen, , Germany

Site Status

Investigational Site, Carl-von-Ossietzky-Straße 151

Chemnitz, , Germany

Site Status

Investigational Site, Clausstraße 44

Chemnitz, , Germany

Site Status

Investigational Site, Unritzstraße 21 c

Chemnitz, , Germany

Site Status

Investigational Site

Cologne, , Germany

Site Status

Investigational Site

Dortmund, , Germany

Site Status

Investigational Site

Dossenheim, , Germany

Site Status

Investigational Site

Düsseldorf, , Germany

Site Status

Investigational Site

Forchheim, , Germany

Site Status

Investigational Site, Eschersheimer Landstr. 544

Frankfurt, , Germany

Site Status

Investigational Site, Im Steinbügel 13

Frankfurt, , Germany

Site Status

Investigational Site

Freiberg, , Germany

Site Status

Investigational Site

Fulda, , Germany

Site Status

Investigational site

Gera, , Germany

Site Status

Investigational Site

Greifswald, , Germany

Site Status

Investigational Site

Halle, , Germany

Site Status

Investigational Site, Neuenfelder Straße 96

Hamburg, , Germany

Site Status

Investigational Site, Sand 35

Hamburg, , Germany

Site Status

Investigational Site, Schweriner Straße 25

Hamburg, , Germany

Site Status

Investigational Site, Tangstedter Landstraße 77

Hamburg, , Germany

Site Status

Investigational Site

Heilbronn, , Germany

Site Status

Investigational Site

Henningsdorf, , Germany

Site Status

Investigational Site

Hermsdorf, , Germany

Site Status

Investigational Site

Kamenz, , Germany

Site Status

Investigational Site

Kulmbach, , Germany

Site Status

Investigational Site

Landsberg/Lech, , Germany

Site Status

Investigational Site

Langenfeld, , Germany

Site Status

Investigational Site

Lübeck, , Germany

Site Status

Investigational Site

Mühlhausen, , Germany

Site Status

Investigational Site

München, , Germany

Site Status

Investigational Site

Neustadt, , Germany

Site Status

Investigational Site, Am Museumsturm 4

Nordhorn, , Germany

Site Status

Investigational Site, Osnabrücker Str. 1

Nordhorn, , Germany

Site Status

Investigational Site

Nuremberg, , Germany

Site Status

Investigational Site

Offenbach, , Germany

Site Status

Investigational Site

Paderborn, , Germany

Site Status

Investigational Site

Pulheim, , Germany

Site Status

Investigational Site

Ribnitz-Damgarten, , Germany

Site Status

Investigational Site

Rostock, , Germany

Site Status

Investigational Site

Rottweil, , Germany

Site Status

Investigational Site

Rüttenscheid, , Germany

Site Status

Investigational Site

Schwerte, , Germany

Site Status

Investigational Site

Tostedt, , Germany

Site Status

Investigational Site

Tönisvorst, , Germany

Site Status

Investigational Site

Weinheim, , Germany

Site Status

Investigational Site

Wilhelmshaven, , Germany

Site Status

Investigational Site

Wolfsburg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FE999303 CS01

Identifier Type: -

Identifier Source: org_study_id